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The roles played by many ncRNAs remain largely unknown. Similarly, relatively little is known about the RNA
binding proteins involved in processing ncRNA. Identiﬁcation of new RNA/RNA binding protein (RBP)
interactions may pave the way to gain a better understanding of the complex events occurring within
cells during gene expression and ncRNA biogenesis. The development of chemical tools for the isolation
of RBPs is of paramount importance. In this context, we report on the synthesis of the uridine
phosphoramidite UDz that bears a diazirine moiety on the nucleobase. RNA probes containing UDz units
were irradiated in the presence of single-stranded DNA binding protein (SSB), which is also known to
bind ssRNAs, and shown to eﬃciently (15% yield) and selectively cross-link to the protein. The
corresponding diazirine-modiﬁed uridine triphosphate UDzTP was synthesized and its capacity to act as a
substrate for the T7 RNA polymerase was tested in transcription assays. UDzTP was accepted with a
maximum yield of 38% for a 26mer RNA containing a single incorporation and 28% yield for triple
consecutive incorporations. Thus, this uridine analogue represents a convenient biochemical tool for the
identiﬁcation of RNA binding proteins and unraveling the role and function played by ncRNAs.1. Introduction
In recent years it has become clear that the roles played by non-
coding RNAs (ncRNAs) are diverse and complex.1–3 Examples of
ncRNAs include not only the classical transfer RNA (tRNA)4 and
ribosomal RNA (rRNA)5 involved in translation, but small
interfering RNA (siRNA),6 micro RNA (miRNA),6,7 small nucle-
olar RNA (snoRNA),8 small nuclear RNA (snRNA)8 and
numerous others that do not t into a distinct category. Each of
these classes of ncRNAs fulls specic functions in all three
domains of life (i.e. Eukarya, Bacteria, and Archaea) during gene
expression, early development,9 and cell maintenance, with an
ever-growing list of diseases10–13 related to unusual ncRNA
behavior hinting at a crucial involvement of these RNAs for
correct cellular function.14 Diﬃculties in identifying the func-
tion of these ncRNAs is oen connected to complications in
diﬀerentiating mRNAs from ncRNAs in bioinformatic
approaches,15 alongside problems generating enough material
with suﬃcient separation to distinguish unique ncRNAs in
experimental procedures.16, University of Bern, Freiestrasse 3, 3012
.unibe.ch; leumann@dcb.unibe.ch; Fax:
(ESI) available: Experimental details of
king experiments, transcription assays,
a08682a
35RNA pathways are extensively regulated by proteins called
RNA binding proteins (RBPs)17–19 and vice versa,20 and together
RNA and RBPs function as ribonucleoprotein (RNP) complexes,
the best known of which are the spliceosome21 and ribosome.5
The inherent association of RNA with proteins has led to the
development of experimental approaches for identifying ncRNA
and RBP function based on the interactions between the two
groups of biomacromolecules. Computational analysis,22–24 X-
ray crystallography25–27 and cross-linking28–34 methods of isola-
tion have all been employed to investigate RNA/RBP interac-
tions. One advantage of cross-linking is that no prior knowledge
of an interaction between a protein and RNA is required. It may
also be used to identify networks of RNA and proteins involved
in forming RNP complexes. Cross-linking between oligonucle-
otides and proteins may be achieved by the addition of external
cross-linking reagents,35–37 or by inducing the cross-link
photochemically with UV light.38,39
The advantage of photochemical cross-linking is that the
natural binding is preserved, which may be disrupted by the
addition of external reagents. Unfortunately, the wavelengths of
UV light required to induce cross-linking between nucleic acids
and proteins (254 nm) are actually damaging to the molecules
and thus have limited applicability in vivo.40 The introduction of
photoreactive groups into nucleic acids, allows for the modu-
lation of the wavelength of UV light needed to achieve reason-
able yields of cross-linking and minimize the potential damage
caused to biomolecules.41 Such modications have included
halides,28,42 inclusion of sulfur atoms,43–45 and the addition ofThis journal is © The Royal Society of Chemistry 2014
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View Article Onlinemore sophisticated moieties such as azides,46,47 and benzo-
phenones.48 In this context, diazirines49–52 have a particular
appeal over their simpler counterparts, as they form carbenes
upon irradiation with long wavelength UV light,53,54 that then
insert into adjacent covalent bonds.55,56 Particularly, p-stabi-
lized carbenes,57,58 such as generated by exposure of 3-tri-
uoromethyl-3-phenyldiazirine54,59 to 365 nm irradiation, have
been used in a wide range of applications.56,60 Examples include:
cross-linking of DNA–protein interactions;49–52,61,62 photoactive
amino acids and peptides for substrate identication;63–65 and
diazirine modied sugars to capture glycoprotein binding
events.66 Further to this, a recent study of commonly used cross-
linkers have identied the triuoromethyldiazirine moiety
superior to benzophenone and phenylazide derivatives, as it
produces simple and accurate cross-linking proles of amyloid
nanostructures.67
The use of diazirines to identify DNA binding protein inter-
actions hints at the possible application of this chemistry to
identify RNA binding proteins. Although 3-triuoromethyl-3-
phenyldiazirine has been used to cross-link RNA previously,68
it involved coupling the photoactive moiety to a 2-thiocytidine
residue already incorporated into a tRNA anticodon loop before
cross-linking it to the ribosome. This strategy has shortcomings
as it can lead to poor eﬃciencies of cross-linking, and the
external addition requires accessibility to the modied base
before cross-linking can be achieved, thus limiting its applica-
tion. Moreover, modied RNA triphosphates (N*TPs) have been
previously synthesized as photoactive substrates for poly-
merases; although the modications have generally been made
on the DNA level, rather than RNA.69 Photo-labelling of viral
proteins during transcription with 5-azidouridine triphos-
phate70 has been described, but the azido functionality is
incompatible with phosphoramidite chemistry, limiting its
applicability. In addition, N*TPs have eﬃciently served in in
vitro selection experiments for the generation of modied
aptamers and ribozymes,71 and this methodology could be
exploited to detect previously unknown interactions between
RNA and proteins and polymerases.Fig. 1 Chemical structures of the photoactive uridine analogues UDz
and UDzTP.
This journal is © The Royal Society of Chemistry 2014Here, we report on the synthesis of the RNA building block
UDz bearing a diazirine moiety on the nucleobase (Fig. 1) with
the intent of developing a new chemical tool for the investiga-
tion of the interaction of RNAs with RBPs.2. Results and discussion
2.1 Design of the probe
We postulated that by incorporating the diazirine moiety within
an RNA probe, through attachment at the C5-position of the
uridine nucleobase, the photoactive RNA probe would be
compatible with a wider range of applications. The choice of the
location of the diazirine photoreactive group was dictated by the
fact that appending modications at the C5-position of pyrim-
idines minimizes structural perturbation of duplexes.72 In
addition, the photoreactive group was connected to the nucle-
obase via a pentynol linker arm that was designed so as to
minimize undesired self-binding to the RNA probe. Therefore, a
diazirine-containing uridine analogue (UDz) was designed to be
incorporated into RNA probes using standard phosphoramidite
chemistry (Fig. 1). The DNA analogue dUDz has been previously
synthesized by Carell et al. and incorporated into DNA strands
opposite a UV induced pyrimidine lesion and was able to
selectively cross-link the DNA lesion repair enzyme DNA pho-
tolyase in the presence of other proteins.48,622.2 Synthesis of the phosphoramidite UDz and nucleoside
triphosphate UDzTP
The synthesis of phosphoramidite UDz followed the synthetic
pathway developed for the corresponding DNA building block.62
Briey, diazirine 1 (ref. 54, 73 and 74) was coupled to 4-pentyn-
1-ol in the presence of NaH, before Sonogashira coupling to the
protected nucleoside 3 (which was prepared via standard DMT
protection of 5-iodouridine) to generate 4, a common precursor
to both UDz and UDzTP (Scheme 1 and ESI†). Indeed, in order to
generate phosphoramidite UDz, 4 was selectively protected at
the 20-OH with TBDMS before phosphitylation under standard
conditions to yield UDz (56% over 2 steps; Scheme 2).
Moreover, UDzTP could be accessed by rst bis-acetylating
compound 4 (71%) and then removing the DMT protectingScheme 1 Synthesis of intermediate 4. Reagents and conditions were
as follows: (i) 4-pentyn-1-ol, NaH, THF, 0 C, 2 h, 68%; (ii) Pd(PPh3)2Cl2,
Et3N, CuI, DMF, r.t., o.n., 84%.
RSC Adv., 2014, 4, 48228–48235 | 48229
Scheme 2 Synthesis of phosphoramidite UDz. Reagents and condi-
tions were as follows: (i) TBDMS-Cl, pyridine, AgNO3, THF, r.t., o.n.,
72%; (ii) CEP-Cl, DIPEA, THF, r.t., 1 h, 78%.
Scheme 3 Synthesis of triphosphate UDzTP. Reagents and conditions
were as follows: (i) Ac2O, pyridine, DMAP, 0 C to r.t., 2 h, 71%; (ii) 1%
DCAA, CH2Cl2, 0 C, 1.5 h, 48%; (iii) (1) 2-chloro-1,3,2-benzodiox-
aphosphorin-4-one, pyridine, dioxane; (2) (nBu3NH)2H2P2O7, nBu3N,
DMF; (3) I2, pyridine, H2O; (4) NH3 (aq.), H2O, 21% (over 4 steps).
Table 1 Biotinylated oligonucleotide sequences used for UV thermal
denaturation experiments and cross-linking experiments (X indicates
the position of the UDz modiﬁcation)
Sequence (50 / 30)
ON1 Biotin-CCUAUGUCACUGAAACUAUCC
ON2 Biotin-CCUAUGUCACUGAAACXAUCC
ON3 Biotin-CCUAUGUCACXGAAACUAUCC
ON4 Biotin-CCXAUGUCACUGAAACUAUCC
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View Article Onlinegroup under acidic conditions (Scheme 3). The suitably pro-
tected intermediate 7 was then converted to the corresponding
triphosphate UDzTP by application of the Ludwig-Eckstein
protocol75,76 and was obtained in 21% aer a thorough semi-
preparative RP-HPLC purication.76Fig. 2 UV thermal melting experiments for ON1-4 versus RNA (A) and
DNA (B).2.3 Oligonucleotide synthesis and thermal stability
The 50-biotinylated 21mer RNA probes were designed for
capture on streptavidin magnetic beads aer cross-linking and
contained single UDz units at diﬀerent locations within the
sequence (ONs 2–4 in Table 1 and ESI†).
Moreover, the sequence composition was chosen so as to
exclude the formation of dimers and tertiary structures. UV
thermal melting measurements for each sequence versus both
the RNA and DNA complements were recorded to assess
whether the modication caused any disturbance in the duplex
stability (Fig. 2). The impact of the modication on the duplex
stability with both the complementary DNA and RNA strands
seems to be negligible (DTm in the range of 1.4 to +0.5 C per
modication; Table 2). A similar behavior has been observed for
other C5-modied uridine analogues,77–79 and therefore modi-
cations located at the C5 position of pyrimidines are well-48230 | RSC Adv., 2014, 4, 48228–48235accommodated in the major groove and do not interfere with
duplex formation and stability.80,81
2.4 Cross-linking experiments
Initial irradiation experiments with the modied oligonucleo-
tides were performed in the presence of the single stranded
DNA binding protein (SSB).82 Although SSB is a DNA binding
protein with a 10-fold lower aﬃnity for ssRNA compared to
ssDNA,83,84 it was deemed suﬃcient for a “proof of concept”
experiment. ON1–4 were 30-end 32P-radiolabelled with T4 RNA
ligase for visualization on the gel and to avoid photobleaching
of potential uorescent tags.85This journal is © The Royal Society of Chemistry 2014
Table 2 Tm values of duplexes of ON1–4 with complementary RNA
and DNA (c(duplex) ¼ 1.0 mM in 10 mM NaH2PO4, 150 mM NaCl, pH
7.0)
Tm vs. RNA (C)
(DTm (C) per mod.)
Tm vs. DNA (C)
(DTm (C) per mod.)
ON1 69.2  1.5 59.6  0.6
ON2 69.6  1.4 (+0.4) 60.0  0.5 (+0.4)
ON3 67.8  1.5 (1.4) 60.1  0.5 (+0.5)
ON4 69.1  0.5 (0.1) 59.5  0.6 (0.1)
Table 3 Quantitation (in percentage) of cross-linking of RNA ON2-4
with the SSB protein
Percentage of cross-linked RNA (relative to free
RNA)
Irradiated with SSB Irradiated RNA
ON2 14.0  0.7 3.4  2.5
ON3 16.2  2.2 5.1  3.0
ON4 16.3  1.6 2.4  1.8
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View Article OnlineThe probes and negative controls were irradiated (l ¼ 375
nm for 30 minutes, in pH 7.8 buﬀer) in the presence of a slight
excess of the SSB protein, and eluted on a 10% tricine SDS
PAGE,86 followed by phosphorimaging (Fig. 3). The irradiation
conditions were chosen so that the diazirine will photolyze into
reactive carbenes, which in turn can insert irreversibly into
nearby CH bonds of the target protein.48,62 The appearance of a
slower running radioactive band (highlighted in red) in Lane 4
of each gel, is consistent with cross-linking of the modied RNA
aer irradiation. Indeed, the appearance of this band was not
observed in the natural control (Lane 5) or in the absence of
irradiation (Lane 2). Moreover, the appearance of a faint, faster
running band in Lane 2 (highlighted in green), indicates that a
higher molecular weight species than the free RNA is formed
under irradiation conditions, in the absence of the protein.
We hypothesize that interstrand cross-linking might occur
by insertion of the carbene generated under irradiation condi-
tions into CH bonds of an adjacent RNA strand, although care
was taken when designing the oligonucleotide sequences to
ensure no hairpin formation or dimerization was likely. The
disappearance of this band in the presence of the protein
underscores the high selectivity and eﬀectiveness of the dia-
zirine photoreactive group incorporated in the RNA sequences.
As a second conrmation of the presence of RNA cross-
linked to the protein, samples of ON1 and ON4 were irradi-
ated in the presence of SSB, before purication with a size
exclusion spin column (30 kDa cut oﬀ), then 30-end 32P-
radiolabelled. The resulting samples were eluted on 10% tri-
cine SDS PAGE, alongside the ON4 sample prepared in the rst
experiment (see ESI Fig. S45†). The radioactive band corre-
sponding to the RNA–SSB crosslinks in both samples with ON4
eluted at the same rate, and the selective nature of radio-
labelling using an RNA ligase conrms the presence of RNA inFig. 3 10% SDS PAGE gels of ON2–3 irradiated in the presence of SSB.
Lane 1: ON. Lane 2: ON irradiated. Lane 3: ON + SSB, non-irradiated.
Lane 4: ON + SSB, irradiated. Lane 5: ON1 + SSB, irradiated.
This journal is © The Royal Society of Chemistry 2014the modied samples, with no such corresponding band in the
natural control, or in the absence of irradiation.
The yields for cross-linking to SSB obtained by quantication
of the respective bands can be found in Table 3. The yield of
cross-linking for each modied strand of RNA was consistently
around 15%, which compares favorably to the crosslinking
yields obtained for DNA probes equipped with diazirine groups
and DNA photolyases.62 The main side reaction competing with
the carbene CH bond insertion in this experiment is the
insertion of H2O. The insertion of H2O is unavoidable in the
unbound RNA, thus, only the probes in contact with the protein
at the moment of excitation are cross-linked. The advantage of
the carbene being quenched by small molecules is that the
resulting RNA will not interfere with data obtained for cross-
linking to macromolecules as they will be resolved easily
under electrophoretic conditions, giving specic cross-linking
proles for a mixture of components. Isolation with streptavi-
din beads was never achieved. Perhaps the bulk of the protein
prevented the biotin from interacting with the beads.2.5 Transcription assays
Nucleoside triphosphates represent a convenient vector for the
introduction of chemical diversity into nucleic acids.87–89 In the
context of ribonucleoside triphosphates (N*TPs), the modi-
cations are usually anchored at the 20-OH of the sugar moiety
and only rarely at the level of the nucleobase.89 Thus, UDzTP was
synthesized and used in transcription assays in order to assess
the compatibility of this heavily-modied uridine analogue with
an RNA polymerase. During transcription RNA polymerases use
a double stranded DNA template to generate single stranded
RNA transcripts. E. coli. T7 RNA polymerase is commonly used
in molecular biology90,91 and has been used to incorporate
N*TPs including 20-uoro- 20-amino-NTPs;92 unnatural base
pairs;93,94 stabilized RNA analogues;95 photoactive monomers
such as 8-azido ATP,96 5-bromo and 5-iodo UTP;28,97 and other 50-
modied UTP analogues.98,99 Matsuda et al. used a 43 base-pair
dsDNA template containing a minimal T7 promoter followed by
the sequence of the transcripts to generate 26 mer products
containing 40-thioRNA nucleotides.95 This dsDNA template was
the basis for the design of the system used to test the incorpo-
ration of UDzTP into RNA oligonucleotides (Fig. 4). Indeed, the
templates generate 26mer RNA transcripts containing a single
(Product P1) or triple consecutive (Product P2) incorporation of
UDz nucleotides. Moreover, in order to assess the eﬃciency ofRSC Adv., 2014, 4, 48228–48235 | 48231
Fig. 4 Incorporation of UDzTP into RNA via transcription assays using
T7 RNA polymerase and dsDNA templates T1/T10 and T2/T20. Italicized
letters represent the T7 promoter sequence.
Table 4 Relative transcription eﬃciency with dsDNA templates
Product P1 Product P2
Eﬃciency compared to
natural transcript (%)
38 28
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View Article Onlinethe incorporation of the modied UDzTP in lieu of its natural
counterpart, the transcription eﬃciencies were measured rela-
tive to that using all natural NTPs which was dened as being
100%.
When the standard conditions for T7 RNA polymerase-
mediated transcription reactions were used, little full lengthFig. 5 Gel images of 20% PAGE of transcription assays using (A)
dsDNA template T1/T10 or (B) template T2/T20. Lane 1: Natural NTPs.
Lane 2: Negative control. Lane 3: UDzTP. Lane 4: ATP and GTP only.
General procedure: 40 pmol of template DNA, 0.4 mM of natural
NTPs, 0.6 mM UDzTP, 100 units of T7 RNA polymerase, 0.6 units of
PPiase, 0.5 ml RNasin, and 10 mCi of a-32P-ATP in the transcription
optimized buﬀer. Reactions were incubated at 37 C: template 1, for at
least 8 hours; template 2 for at least 24 hours; under 20 ml mineral oil.
48232 | RSC Adv., 2014, 4, 48228–48235products could be observed when UDzTP was included (data not
shown). On the other hand, optimized reaction conditions, i.e.
increased concentrations of UDzTP and longer reaction times,
(vide infra), led to the appearance of bands corresponding to full
length products when UDzTP was used as a substitute for UTP
(Lane 3 in Fig. 5A and B). This conrms the ability of T7 RNA
polymerase to accept this heavily modied N*TP as a substrate.
Moreover, the absence in Lane 3 of similar abortive sequences
as shown in the negative control experiments (Lanes 2 and 4) is
in agreement with this statement and shows that the polymer-
ization reactions proceed with high yields. Interestingly, the T7
RNA polymerase could readily incorporate three modied
UDzTP in a row (Fig. 5B) without stalling, clearly showing that
this N*TP is a rather good substrate for the polymerase.
However, the transcription eﬃciencies are rather depleted
when compared to those obtained with the unmodied UTP
(Table 4) hinting at a slowing of transcription due to the pres-
ence of the N*TP. This is conrmed by the fact that the reaction
times had to be extended (to at least 8 and 24 hours for the
dsDNA templates T1/T10 and T2/T20, respectively) during opti-
mization to allow the synthesis of the modied RNA. The
polymerase was unable to generate the full length transcript
with the exact template used by Matsuda et al. which should
lead to six incorporations of UDzTP (data not shown). There also
seems to be a position dependence on the ability of the enzyme
to incorporate UDzTP, since using a template containing
complementary A nucleotides at positions 10, 15 and 21
(template T3/T30, Table S2, ESI†) only led to abortive sequences
(data not shown).
However, a longer template T4/T40 designed to generate a
52mer RNA product (consisting the sequences of templates T1/
T10 and T3/T30 appended onto one another Table S2, ESI†)
containing 4 modications dispersed throughout the transcript
did generate full length transcripts, in a similar yield (37%) and
time scale (26 hours) as the other templates (Fig. S46, ESI†).3. Conclusions
With the intent of developing a new tool for the investigation of
RNA–protein interactions, a photoreactive diazirine-containing
uridine analogue was designed so that it could be incorporated
into RNA, either synthetically via phosphoramidite chemistry
(UDz) or by enzymatic polymerization (UDzTP).
The modied RNA oligonucleotides obtained by incorpora-
tion of the phosphoramidite building block during solid-phase
synthesis served two purposes: (1) assessing the eﬀect of the
modication on duplex stability and (2) showing that the
inclusion of the photoreactive diazirine moiety into RNAs could
serve as a versatile tool for the investigation of RNA–proteinThis journal is © The Royal Society of Chemistry 2014
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View Article Onlineinteractions. Not surprisingly, UV-melting experiments revealed
that the modication did not cause any disruption of the Wat-
son–Crick base-pairing and was well-tolerated in the major
groove of the duplexes. Moreover, the resulting synthetic probes
were assessed for cross-linking potential to single-stranded
binding protein (SSB) in an irradiation assay. The RNA probes
containing the modied uridine analogue were selectively
cross-linked to SSB. The selectivity of this assay derives from the
main competitor of the CH bond insertion of the protein, being
the insertion of H2O, thus only molecules in direct contact with
the modied RNA will be cross-linked, preventing non-specic
cross-linking. Even though the SSB mainly served as a para-
digm for the development of photo-crosslinking RNA probes,
this approach can be extended to investigate on the binding
mode of other single-stranded nucleic acid binding proteins.
Indeed, the virus-encoded single-stranded DNA binding protein
ICP8 was shown to bind to ssRNA with an aﬃnity only 5 fold
lower than that of ssDNA, hinting at a possible implication of
ICP8 in the regulation of viral replication.84 Finally, other yet
unknown proteins binding to various forms of coding or non-
coding RNAs could be easily targeted by application of this
general method.
The ability of T7 RNA polymerase to accept the triphosphate
analogue was also investigated in transcription assays, gener-
ating modied RNA containing up to four incorporations of the
diazirine-modied uridine. The eﬃcient transcription reactions
with UDzTP show that bulkier modications are also tolerated at
this particular location. In this context, various investigations
have shown that UTP analogues equipped with smaller modi-
cations such as hydrophobic moieties,98 amines, thiols,79,100
and azides101 acted as good substrates for the T7 RNA poly-
merase. Thus, the T7 RNA polymerase is rather tolerant to a
broad variety of modications anchored at position C5 of
pyrimidine nucleoside triphosphates.
However, the rate of transcription seems to be retarded by
the presence of the modied UTP. A kinetic investigation on the
eﬀect of the analogue UDzTP on the catalytic eﬃciency (kcat/KM)
is currently under way and will shed some light on this
phenomenon. Finally, the substrate acceptance of the non-
canonical UDzTP analogue might be further improved by using
mutant RNA polymerases.102
Overall, the good substrate acceptance of triphosphate
UDzTP and the photo-crosslinking ability of the probes con-
taining the uridine analogue UDz bode well for the isolation and
identication of RNA binding proteins and ncRNAs as well as
understanding their interactions.
4. Experimental section
4.1 Cross-linking experiments
Single-stranded DNA binding protein (SSB) (1 mg, 10 pmol) and
oligonucleotide (3 pmol of radiolabelled RNA) were incubated
in the irradiation buﬀer (50 mMTris-HCl, 10mMMgCl2, 10 mM
DTT, pH 7.8) in a total volume of 15 ml in a PCR vial at room
temperature for at least 30 minutes prior to irradiation. The
sample was irradiated at 375 nm for 30 minutes. Loading buﬀer
(70% formamide, 50 mM EDTA, bromophenol blue and xyleneThis journal is © The Royal Society of Chemistry 2014cyanol FF (each 0.1%) 15 ml) was then added and heated to 95 C
for 5 minutes. The resulting RNA–protein complexes were then
resolved on 10% SDS-PAGE at 10 W for 2 hours. The gel was
exposed on an imaging plate at 18 C overnight before visu-
alizing on a phosphorimager.
4.2 Transcription assays
General procedure: 40 pmol of ds template DNA were annealed
by heating to 95 C and then gradually cooling down to room
temperature. 0.4 mM of natural NTPs, 0.6 mM UDzTP, 100 units
of T7 RNA polymerase, 0.6 units of PPiase, 0.5 ml RNasin, and 10
mCi of a-32P-ATP were then added at 0 C to the transcription
optimized buﬀer composed of 40 mM Tris–HCl (pH 7.9), 6 mM
MgCl2, 10 mM NaCl, 2 mM spermidine, 10 mM DTT and 0.05%
of the polysorbate detergent Tween, and made up to a total
volume of 20 ml with ultra-pure H2O. Reactions were incubated
at 37 C for diﬀerent reaction times: template T1, 8 hours;
template T2 24 hours; under 20 ml mineral oil. The reactions
were quenched by adding of 20 mL of stop solution (70%
formamide, 50 mM EDTA, 0.1% bromophenol, 0.1% xylene
cyanol) and resolved on 15–20% PAGE.
5. AbbreviationsUDz Diazirine modied uridine phosphosphoramidite
UDzTP Diazirine modied uridine triphosphate;
N*TP Modied nucleoside triphosphate
Tris Tris(hydroxymethyl)aminomethane
TBDMS tert-Butyldimethylsilyl
RP-
HPLCReversed phase high-performance liquid
chromatographyTm Melting temperature
ON Oligonucleotide
T Template
P Product
DMF Dimethyl formamide
nBu3N n-Tributylamine
DCAA Dichloroacetic acid
DIPEA N,N-Diisopropylethylamine
CEP-Cl 20-Cyanoethyl N,N-
diisopropylchlorophosphoramidite
r.t. Room temperature
o.n. Overnight
DMAP 4-DimethylaminopyridineAcknowledgements
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